🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Evonik sees 2023 profit at low end of forecast despite Q1 beat

Published 09/05/2023, 06:23
Updated 09/05/2023, 08:48
© Reuters. FILE PHOTO: The logo of German specialty chemical company Evonik Industries AG is pictured at their plant in Bitterfeld, Germany, February 29, 2016.        REUTERS/Fabrizio Bensch/File Photo
EVKn
-

(Reuters) -German chemicals group Evonik Industries on Tuesday said it expected 2023 earnings at the low end of its earlier forecast, even as higher prices helped it beat first-quarter profit expectations.

Evonik, whose products are used in items from animal feed and diapers to Pfizer/BioNTech's COVID-19 vaccine, had previously guided for adjusted core earnings (EBITDA) of 2.1 billion to 2.4 billion euros for the full year. Analysts polled by Vara Research had expected it to reach 2.19 billion euros.

The shares fell 2.8% after the market opened before taking back some losses to trade down 1%.

The company attributed the downbeat outlook to falling prices for animal feed additive methionine and for products of the C4 chain in its performance materials unit.

Evonik, a market leader in the production of amino acids for poultry feeds, has been shifting its strategic focus towards high-margin speciality chemicals such as animal nutrition.

The group had in April said it would cut 200 jobs in the pet food unit as it aims to streamline its operations.

It said on Tuesday the planned sale of its superabsorbents business, a part of the performance materials division, was also progressing according to plan.

Evonik posted a 44% decline in first-quarter adjusted EBITDA to 409 million euros ($450.23 million), but beat analysts' forecast of 391.9 million euros, as pricing offset some of the lost volumes in the quarter marked by muted economic activity.

© Reuters. FILE PHOTO: The logo of German specialty chemical company Evonik Industries AG is pictured at their plant in Bitterfeld, Germany, February 29, 2016.        REUTERS/Fabrizio Bensch/File Photo

"The start to the year was even more challenging than we feared," CEO Christian Kullmann said in a statement, but added the company had seen signs of business recovery over the course of the quarter.

($1 = 0.9084 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.